Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01720355 · ClinicalTrials.gov registry record
Pulse Oximetry- Performance During Severe Signal Interference
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 17
- Enrollment target
NCT01720355: Completed study, sponsored by Medtronic - MITG.
NCT01720355 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01720355 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
Determine accuracy specifications and labeling claims of a pulse oximeter in a diverse subject population during severe signal interference over a specified saturation range.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-08 |
| Est. Completion | 2012-11 |
What the finished NCT01720355 record still lists
NCT01720355 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01720355 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01720355 about?
NCT01720355 is a clinical study titled "Pulse Oximetry- Performance During Severe Signal Interference". Determine accuracy specifications and labeling claims of a pulse oximeter in a diverse subject population during severe signal interference over a specified saturation range.
What is the current status of trial NCT01720355?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2012-08. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT01720355?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia